Dubroff: Lawsuit vs. Google could pave way for Central Coast companies
Columns, Latest news, Opinion, Subscriber contentThis article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Dubroff: Small business recovery should be part of the POTUS visit to the region
Columns, Latest news, OpinionWhen Joe Biden arrives on the Central Coast during his expected tour of storm damage, the unspoken issue won’t be the missing documents found at his former office and current residence in Delaware. Those questions will likely get plenty of airtime. But the unspoken questions will be what has happened to the small business haven Read More →
Dubroff: California must adapt its water policies after huge downpour
Columns, Latest news, OpinionThis article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Dubroff: Five droughts that could come to an end in 2023
Columns, Latest news, OpinionThis article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Dubroff: Direct Relief’s digs deep for funds to help Ukraine endure
Columns, Latest news, Subscriber contentThis article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Despite critics, Amgen sticks to its game plan
Health Care & Life Science, Technology, Top 25 lists, Top Stories, Top StoryDuring its 42 years as a biotech company based in Thousand Oaks, Amgen has fiercely protected its independence, while rising to the top ranks of pharma companies, often by acquiring companies with drugs. The blockbuster transaction announced on Dec. 12 to acquire Horizon Therapeutics fits that growth pattern and it matches up with the company’s Read More →
Paseo Nuevo could be the key to Santa Barbara downtown redevelopment
ColumnsThis article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
